openPR Logo
Press release

T-cell Therapy Market : Global Industry Trends, Growth, Opportunity And Forecast 2023-2031 : Report By Global Insight Services

12-04-2023 11:40 AM CET | Health & Medicine

Press release from: Global Insight Services

/ PR Agency: Global Insight Services
T-cell Therapy Market : Global Industry Trends, Growth,

The T-cell therapy market has witnessed remarkable growth and innovation, revolutionizing the landscape of cancer treatment. Harnessing the power of the immune system, particularly T-cells, this therapy involves genetically modifying a patient's own T-cells to recognize and attack cancer cells more effectively. The approval of groundbreaking therapies like CAR-T (Chimeric Antigen Receptor T-cell) therapies has paved the way for significant advancements in the field.

Request for Free Sample @ https://www.globalinsightservices.com/request-sample/GIS21392/?utm_source=SnehaPatil&utm_medium=Openpr&utm_campaign=04122023

The market is characterized by continuous research, technological advancements, and collaborations aimed at enhancing the efficacy and safety profiles of T-cell therapies. Ongoing clinical trials across various cancer types and the expansion of manufacturing capabilities to meet the increasing demand underscore the immense potential of T-cell therapies in providing targeted and personalized treatment options, propelling the market toward further expansion and development.

Key Trends

A key trend shaping the T-cell therapy market is the exploration and development of off-the-shelf or allogeneic T-cell therapies. This trend aims to address the challenges associated with the current autologous T-cell therapies, such as the lengthy and complex manufacturing process requiring patient-specific cells. Allogeneic T-cell therapies utilize donor-derived cells that are genetically modified to reduce the risk of rejection and graft-versus-host disease (GVHD). The development of universal or "off-the-shelf" T-cell products holds the promise of broader accessibility, reduced manufacturing costs, and quicker availability for patients. Research and advancements in gene editing technologies, such as CRISPR/Cas9, are driving efforts to create universal donor cells, enabling wider application.

Read Full Research Report @ https://www.globalinsightservices.com/reports/t-cell-therapy-market/?utm_source=SnehaPatil&utm_medium=Openpr&utm_campaign=04122023

Key Drivers

An essential driver propelling the T-cell therapy market is the persistent demand for innovative and targeted cancer treatments coupled with the encouraging clinical outcomes observed in T-cell therapies. The growing prevalence of various cancers worldwide has amplified the urgency for effective therapies, stimulating substantial investment and research in T-cell-based immunotherapy. Moreover, the regulatory approvals and commercial success of pioneering T-cell therapies like CAR-T (Chimeric Antigen Receptor T-cell) treatments have bolstered confidence in the potential of this approach. Advancements in understanding tumor biology, coupled with advancements in genetic engineering and biotechnology, have accelerated the development of novel T-cell therapies, fostering a conducive environment for market growth.

Buy Now@ https://www.globalinsightservices.com/checkout/single_user/GIS21392/?utm_source=SnehaPatil&utm_medium=Openpr&utm_campaign=04122023

Market Segmentation : T-cell Therapy Market

T-cell Therapy Market By Modality : Rsearch, Commercialized

T-cell Therapy Market By Therapy Type : CAR T-cell Therapy, T-cell Receptor (TCR)-based, Tumor Infiltrating Lymphocytes (TIL)-based

T-cell Therapy Market By Indication : Hematologic Malignancies, Solid Tumors, Others

T-cell Therapy Market Immunohistochemistry (IHC) Market By Region : North America : US, Canada, Mexico, Europe : The UK, Germany, France, Italy, Spain, Netherlands, Switzerland, Asia-Pacific : China, India, Japan, South Korea, Australia, Singapore, Indonesia, Rest of Asia-Pacific, Rest of the World : Latin America, Middle East, Africa

Key Players :

Amgen (US)
Bluebird Bio Inc. (US)
Fate Therapeutics (US)
Gilead Sciences Inc. (US)
Merck KGaA (Germany)
Novartis AG (Switzerland)
Pfizer Inc. (US)
Sorrento Therapeutics (US)
TCR² Therapeutics (US)
TScan Therapeutics, Inc. (US)

Request for Customization @https://www.globalinsightservices.com/request-customization/GIS21392/?utm_source=SnehaPatil&utm_medium=Openpr&utm_campaign=04122023

With Global Insight Services, you receive :

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

Contact Us :

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 15998
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services :

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release T-cell Therapy Market : Global Industry Trends, Growth, Opportunity And Forecast 2023-2031 : Report By Global Insight Services here

News-ID: 3314154 • Views:

More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing at 17.5% CAGR | Overall Study Report
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Overall Study Report
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAGR | Key Players: EasyMile, Navya, Aurrigo
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | Key Players: Apollo Tyres, Nokian Tyres, Hankook Tire
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire

All 5 Releases


More Releases for Therapy

Visual Arts Therapy Market Future Business Opportunities 2024-2031 | American Ar …
A recent report titled "Visual Arts Therapy Market" Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The report additionally features a comprehensive table of contents, figures, tables, and charts, as well as an analysis of the data. The Visual
Hair Transplant Market by Therapy (Platelet-Rich Plasma Therapy (PRP), Stem Cell …
Hair transplant refers to the market for surgical procedures aimed at restoring hair growth in individuals experiencing hair loss or baldness. These procedures involve the transplantation of hair follicles from one part of the body to the balding or thinning areas. View Detailed Report" https://www.databridgemarketresearch.com/reports/global-hair-transplant-market The expansion of biotechnology sector across the globe, acts as one of the major factors driving the growth of global hair transplant market. The increase in the
Melanoma Therapeutics Market By Chemotherapy, Biologic therapy, Targeted therapy …
Melanoma market has witnessed an unprecedented boost in market size, owing to a dynamically evolving nature of melanoma treatments over the past few years. The high demand of novel early stage and advanced melanoma therapies along with a booming patient base, has created an impending need for better therapies in the melanoma market. Although, a plethora of treatment options are available today, several immunotherapies and combination therapies are expected to
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by
Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
Physical Therapy Supplies Market is classified into physical therapy services, o …
As per The Institute of Physical Therapy and Applied Science, physical therapy is a holistic approach based on the manual treatment of soft tissues, i.e. muscles, tendons, ligaments and fascia. Hence, physical therapy differs greatly from physiotherapy as it does not specially treat the spine. The main equipment used for physical therapy include ramps, exercise balls, resistance exercise bands, Nordic Track, treatment tables, ultrasound, Isokinetic devices, electrical muscle stimulation equipment,